William Blair & Company
TERN

William Blair & Company’s Terns Pharmaceuticals TERN Stock Holding History

William Blair & Company’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,947
Closed -$419K – 2066
2026
Q1 		$419K Buy
7,947
+1,897
+31% +$77.9K ﹤0.01% 1208
2025
Q4 		$244K Buy
+6,050
New +$140K ﹤0.01% 1385

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

William Blair & Company's TERN Position: Q2 2026 in Review

William Blair & Company sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,947 shares — an estimated $419K sold.

William Blair & Company first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $419K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • William Blair & Company reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • William Blair & Company sold 7,947 Terns Pharmaceuticals shares in Q2 2026, an estimated $419K.
  • William Blair & Company first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • William Blair & Company's Terns Pharmaceuticals position peaked at $419K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.